As of 2026-09-13, the EV/EBITDA ratio of Silk Road Medical Inc (SILK) is -20.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SILK's latest enterprise value is 1,170.43 mil USD. SILK's TTM EBITDA according to its financial statements is -57.03 mil USD. Dividing these 2 quantities gives us the above SILK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 16.2x | 15.0x |
| Forward P/E multiples | 12.6x - 16.4x | 14.5x |
| Fair Price | (20.55) - (24.05) | (21.98) |
| Upside | -174.7% - -187.5% | -180.0% |
| Date | EV/EBITDA |